Medicofarma Biotech S.A.

WAR:MDB Poland Biotechnology & Medical Research
Market Cap
$832.69
zł3.46K PLN
Market Cap Rank
#48373 Global
#553 in Poland
Share Price
zł0.38
Change (1 day)
-6.02%
52-Week Range
zł0.25 - zł0.51
All Time High
zł6.95
About

Medicofarma Biotech S.A. operates in Biotechnology.

Market Cap & Net Worth: Medicofarma Biotech S.A. (MDB)

Medicofarma Biotech S.A. (WAR:MDB) has a market capitalization of $832.69 (zł3.46K) as of March 18, 2026. Listed on the WAR stock exchange, this Poland-based company holds position #48373 globally and #553 in its home market, demonstrating a 29.31% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medicofarma Biotech S.A.'s stock price zł0.38 by its total outstanding shares 9233 (9.23K).

Medicofarma Biotech S.A. Market Cap History: 2015 to 2026

Medicofarma Biotech S.A.'s market capitalization history from 2015 to 2026. Data shows change from $843.79 to $832.69 (-1.33% CAGR).

Medicofarma Biotech S.A. Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Medicofarma Biotech S.A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

No P/S ratio data available

Latest Price to Earnings (P/E) Ratio

No P/E ratio data available

What These Ratios Tell Investors:
  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
No financial ratio data available

Competitor Companies of MDB by Market Capitalization

Companies near Medicofarma Biotech S.A. in the global market cap rankings as of March 18, 2026.

Key companies related to Medicofarma Biotech S.A. by market ranking:

  • Peptron Inc (KQ:087010): Ranked #3322 globally with a market cap of $3.92 Billion USD ( ₩5.74 Trillion KRW).
  • MEDIPOST Co. Ltd (KQ:078160): Ranked #15247 globally with a market cap of $192.41 Million USD ( ₩281.72 Billion KRW).
  • Bioneer Corporation (KQ:064550): Ranked #15689 globally with a market cap of $175.97 Million USD ( ₩257.66 Billion KRW).
  • Macrogen Inc (KQ:038290): Ranked #18272 globally with a market cap of $99.40 Million USD ( ₩145.55 Billion KRW).

Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#3322 Peptron Inc KQ:087010 $3.92 Billion ₩311000.00
#15247 MEDIPOST Co. Ltd KQ:078160 $192.41 Million ₩22200.00
#15689 Bioneer Corporation KQ:064550 $175.97 Million ₩12100.00
#18272 Macrogen Inc KQ:038290 $99.40 Million ₩16410.00

Medicofarma Biotech S.A. Historical Marketcap From 2015 to 2026

Between 2015 and today, Medicofarma Biotech S.A.'s market cap moved from $843.79 to $ 832.69, with a yearly change of -1.33%.

Year Market Cap Change (%)
2026 zł832.69 -6.02%
2025 zł885.98 +2.84%
2024 zł861.55 -64.24%
2023 zł2.41K -6.06%
2022 zł2.56K -32.06%
2021 zł3.77K -41.78%
2020 zł6.48K +848.05%
2019 zł683.91 +54.00%
2018 zł444.10 -52.38%
2017 zł932.61 -33.33%
2016 zł1.40K +65.79%
2015 zł843.79 --

End of Day Market Cap According to Different Sources

On Mar 18th, 2026 the market cap of Medicofarma Biotech S.A. was reported to be:

Source Market Cap
Yahoo Finance $832.69 USD
MoneyControl $832.69 USD
MarketWatch $832.69 USD
marketcap.company $832.69 USD
Reuters $832.69 USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.